{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:08:17Z","timestamp":1786540097711,"version":"build-2736575974"},"reference-count":7,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jocn.2015.05.032","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T11:47:59Z","timestamp":1437047279000},"page":"1979-1981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria"],"prefix":"10.1016","volume":"22","author":[{"given":"Jennifer","family":"Watts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Brew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2015.05.032_b0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0165-6147(85)90033-1","article-title":"The pharmacological mechanism of botulism","volume":"6","author":"Sellin","year":"1985","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jocn.2015.05.032_b0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mus.880140711","article-title":"Distant effects of locally injected botulinum toxin: a double-blinded study of single fibre EMG changes","volume":"14","author":"Lange","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2015.05.032_b0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mds.870090319","article-title":"Botulinum toxin for spasmodic torticollis in a patient with myasthenia gravis","volume":"9","author":"Emmerson","year":"1994","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2015.05.032_b0020","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/1531-8257(200007)15:4<736::AID-MDS1023>3.0.CO;2-9","article-title":"Myasthenia gravis after botulinum toxin A for Meige syndrome","volume":"15","author":"Tarsy","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2015.05.032_b0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00417-005-0130-4","article-title":"Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis","volume":"244","author":"Iwase","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jocn.2015.05.032_b0030","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00702-010-0481-9","article-title":"Subclinical Myasthenia Gravis causing increased sensitivity to botulinum toxin therapy","volume":"117","author":"Dressler","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jocn.2015.05.032_b0035","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/dsu.12022","article-title":"OnabotulinumtoxinA unmasking myasthenia gravis","volume":"39","author":"Glick","year":"2013","journal-title":"Dermatol Surg"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758681500315X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758681500315X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T18:52:35Z","timestamp":1537469555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096758681500315X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":7,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S096758681500315X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2015.05.032","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2015.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}